Cerity Partners’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,478
| Closed | -$239K | – | 2537 |
|
|
2024
Q4 | $239K | Buy |
+4,478
| New | +$239K | ﹤0.01% | 2156 |
|
|
2024
Q2 | – | Sell |
-21,431
| Closed | -$807K | – | 2310 |
|
|
2024
Q1 | $807K | Sell |
21,431
-39,502
| -65% | -$1.49M | ﹤0.01% | 1370 |
|
|
2023
Q4 | $654K | Buy |
+60,933
| New | +$654K | ﹤0.01% | 1153 |
|
|
2023
Q3 | – | Sell |
-60,933
| Closed | -$723K | – | 1553 |
|
|
2023
Q2 | $723K | Buy |
+60,933
| New | +$723K | ﹤0.01% | 1037 |
|
|
2022
Q4 | – | Sell |
-105,933
| Closed | -$1.43M | – | 1509 |
|
|
2022
Q3 | $1.43M | Sell |
105,933
-45,000
| -30% | -$609K | 0.02% | 435 |
|
|
2022
Q2 | $1.84M | Hold |
150,933
| – | – | 0.02% | 422 |
|
|
2022
Q1 | $2.16M | Hold |
150,933
| – | – | 0.03% | 318 |
|
|
2021
Q4 | $2.98M | Buy |
+150,933
| New | +$2.98M | 0.05% | 261 |
|